BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17257903)

  • 1. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis.
    Singh SK; Bhusari S; Singh R; Saxena A; Mondhe D; Qazi GN
    Vascul Pharmacol; 2007 May; 46(5):333-7. PubMed ID: 17257903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity.
    Kragh M; Hjarnaa PJ; Bramm E; Kristjansen PE; Rygaard J; Binderup L
    Int J Oncol; 2003 Feb; 22(2):305-11. PubMed ID: 12527927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay.
    Wake H; Mori S; Liu K; Takahashi HK; Nishibori M
    Eur J Pharmacol; 2009 Nov; 623(1-3):89-95. PubMed ID: 19786011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
    Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
    Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
    Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis.
    Moon EJ; Lee YM; Kim KW
    Oncol Rep; 2003; 10(3):617-21. PubMed ID: 12684633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; BĂ©liveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A versatile in vivo chamber angiogenesis assay for measuring anti-angiogenic activity in mice.
    Kragh M; Hjarnaa PJ; Bramm E; Binderup L
    Oncol Rep; 2004 Feb; 11(2):303-7. PubMed ID: 14719059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of huangqi and dangshen extraction on angiogenesis in Matrigel implant of mice].
    Bai CQ; Song YF; Jian W; Wang DT; Ma CB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):498-9. PubMed ID: 18466712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis.
    Wilasrusmee C; Yusupov I; Ondocin P; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
    Int Angiol; 2005 Dec; 24(4):372-9. PubMed ID: 16355096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
    Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
    Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance.
    Kimura Y; Taniguchi M; Baba K
    Anticancer Res; 2002; 22(6A):3309-18. PubMed ID: 12530080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model.
    Saraswati S; Pandey M; Mathur R; Agrawal SS
    Microvasc Res; 2011 Nov; 82(3):263-8. PubMed ID: 21864545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
    Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
    J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor suspended in Matrigel improves titanium implant fixation in ovariectomized rats.
    Gao Y; Zhu S; Luo E; Li J; Feng G; Hu J
    J Control Release; 2009 Oct; 139(1):15-21. PubMed ID: 19482052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
    Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
    Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dobesilate is an angiogenesis inhibitor.
    Cuevas P; Sanchez I; Lozano RM; Gimenez-Gallego G
    Eur J Med Res; 2005 Sep; 10(9):369-72. PubMed ID: 16183547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
    Jazowiecka-Rakus J; Jarosz M; Szala S
    Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
    Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
    Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.